What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
His primary scientific interests are in Mycosis, Internal medicine, Amphotericin B, Aspergillosis and Microbiology.
Mycosis is a subfield of Immunology that Thomas J. Walsh investigates.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Surgery.
The various areas that he examines in his Amphotericin B study include Pharmacokinetics, Pharmacology and Itraconazole.
Thomas J. Walsh has included themes like Hematopoietic stem cell transplantation, Disease, Transplantation, Intensive care medicine and Voriconazole in his Aspergillosis study.
His Intensive care medicine study combines topics in areas such as Clinical trial, Epidemiology, MEDLINE, Mucormycosis and Antifungal.
His most cited work include:
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group (3691 citations)
- Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. (2609 citations)
- Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America (2130 citations)
What are the main themes of his work throughout his whole career to date?
Thomas J. Walsh focuses on Microbiology, Internal medicine, Amphotericin B, Immunology and Aspergillosis.
His research integrates issues of Gastroenterology, Surgery and Oncology in his study of Internal medicine.
His Amphotericin B research includes elements of Pharmacokinetics, Pharmacology, Fluconazole and Mycosis.
As part of his studies on Aspergillosis, Thomas J. Walsh often connects relevant subjects like Intensive care medicine.
His Intensive care medicine study combines topics from a wide range of disciplines, such as Mucormycosis, Antifungal, Clinical trial and Epidemiology.
As a member of one scientific family, Thomas J. Walsh mostly works in the field of Caspofungin, focusing on Echinocandin and, on occasion, Micafungin and Anidulafungin.
He most often published in these fields:
- Microbiology (25.31%)
- Internal medicine (21.52%)
- Amphotericin B (17.46%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (21.52%)
- Intensive care medicine (13.14%)
- Microbiology (25.31%)
In recent papers he was focusing on the following fields of study:
Thomas J. Walsh spends much of his time researching Internal medicine, Intensive care medicine, Microbiology, Antifungal and Pharmacokinetics.
His biological study spans a wide range of topics, including Gastroenterology and Oncology.
His studies in Intensive care medicine integrate themes in fields like Epidemiology, Guideline, Mucormycosis, Disease and Aspergillosis.
His Aspergillosis research is classified as research in Immunology.
As part of his studies on Microbiology, Thomas J. Walsh often connects relevant areas like Klebsiella pneumoniae.
His Pharmacokinetics study deals with the bigger picture of Pharmacology.
Between 2015 and 2021, his most popular works were:
- Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America (1207 citations)
- Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America (1008 citations)
- Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America (840 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
